208 related articles for article (PubMed ID: 29374558)
1. Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation.
Ren XL; Qiao YD; Li JY; Li XM; Zhang D; Zhang XJ; Zhu XH; Zhou WJ; Shi J; Wang W; Liao WT; Ding YQ; Liang L
Cancer Lett; 2018 Apr; 419():245-256. PubMed ID: 29374558
[TBL] [Abstract][Full Text] [Related]
2. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
3. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
[TBL] [Abstract][Full Text] [Related]
5. IKKε phosphorylates kindlin-2 to induce invadopodia formation and promote colorectal cancer metastasis.
Liu G; Bao Y; Liu C; Zhu Q; Zhao L; Lu X; Zhu Q; Lv Y; Bai F; Wen H; Sun Y; Zhu WG
Theranostics; 2020; 10(5):2358-2373. PubMed ID: 32104508
[TBL] [Abstract][Full Text] [Related]
6. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia.
Oser M; Mader CC; Gil-Henn H; Magalhaes M; Bravo-Cordero JJ; Koleske AJ; Condeelis J
J Cell Sci; 2010 Nov; 123(Pt 21):3662-73. PubMed ID: 20971703
[TBL] [Abstract][Full Text] [Related]
7. Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function.
Beghein E; Devriese D; Van Hoey E; Gettemans J
Sci Rep; 2018 Oct; 8(1):15606. PubMed ID: 30353022
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the functional domain requirements of cortactin in invadopodia formation.
Webb BA; Jia L; Eves R; Mak AS
Eur J Cell Biol; 2007 Apr; 86(4):189-206. PubMed ID: 17343955
[TBL] [Abstract][Full Text] [Related]
9. Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion.
Markwell SM; Ammer AG; Interval ET; Allen JL; Papenberg BW; Hames RA; Castaño JE; Schafer DA; Weed SA
Mol Cancer Res; 2019 Apr; 17(4):987-1001. PubMed ID: 30610108
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.
Zhu XL; Liang L; Ding YQ
Int J Colorectal Dis; 2008 Nov; 23(11):1041-7. PubMed ID: 18665374
[TBL] [Abstract][Full Text] [Related]
12. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
Clark ES; Whigham AS; Yarbrough WG; Weaver AM
Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
[TBL] [Abstract][Full Text] [Related]
13. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.
Zhu XL; Zeng YF; Guan J; Li YF; Deng YJ; Bian XW; Ding YQ; Liang L
J Pathol; 2011 Jul; 224(3):377-88. PubMed ID: 21506128
[TBL] [Abstract][Full Text] [Related]
14. Mena
Weidmann MD; Surve CR; Eddy RJ; Chen X; Gertler FB; Sharma VP; Condeelis JS
Sci Rep; 2016 Nov; 6():36142. PubMed ID: 27824079
[TBL] [Abstract][Full Text] [Related]
15. FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer.
Yang SS; Li XM; Yang M; Ren XL; Hu JL; Zhu XH; Wang FF; Zeng ZC; Li JY; Cheng ZQ; Liao WT; Ding YQ; Guan J; Liang L
Br J Cancer; 2017 Oct; 117(8):1164-1175. PubMed ID: 28817833
[TBL] [Abstract][Full Text] [Related]
16. Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells.
Bertier L; Hebbrecht T; Mettepenningen E; De Wit N; Zwaenepoel O; Verhelle A; Gettemans J
Biomed Pharmacother; 2018 Jun; 102():230-241. PubMed ID: 29567535
[TBL] [Abstract][Full Text] [Related]
17. A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis.
Twafra S; Sokolik CG; Sneh T; Srikanth KD; Meirson T; Genna A; Chill JH; Gil-Henn H
Oncogene; 2023 Jan; 42(4):278-292. PubMed ID: 36258022
[TBL] [Abstract][Full Text] [Related]
18. Cortactin function in invadopodia.
Jeannot P; Besson A
Small GTPases; 2020 Jul; 11(4):256-270. PubMed ID: 29172953
[TBL] [Abstract][Full Text] [Related]
19. A new role for cortactin in invadopodia: regulation of protease secretion.
Clark ES; Weaver AM
Eur J Cell Biol; 2008 Sep; 87(8-9):581-90. PubMed ID: 18342393
[TBL] [Abstract][Full Text] [Related]
20. Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
Yamaguchi H; Ito Y; Miura N; Nagamura Y; Nakabo A; Fukami K; Honda K; Sakai R
Eur J Cell Biol; 2017 Oct; 96(7):685-694. PubMed ID: 28797528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
